Małgorzata Mizerska-Wasiak

The MEST score provides earlier risk prediction in lgA nephropathy

Sean J. Barbour, Gabriela Espino-Hernández, Heather N. Reich et al. · Kidney International · 2015 · 289 citations · Full text

Medicine, Internal Medicine, Nephrology +10

The copy number variation landscape of congenital anomalies of the kidney and urinary tract

Miguel Verbitsky, Rik Westland, Alejandra Perez et al. · Nature Genetics · 2018 · 239 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

Krzysztof Kiryluk, Elena Sánchez, Francesca Zanoni et al. · Nature Genetics · 2023 · 172 citations · Full text

Life Sciences, Bioinformatics, Nephrology +17

Genetic Drivers of Kidney Defects in the DiGeorge Syndrome

Esther López-Rivera, Yangfan P. Liu, Miguel Verbitsky et al. · New England Journal of Medicine · 2017 · 154 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

Rosanna Coppo, Graziella D’Arrigo, Giovanni Tripepi et al. · Nephrology Dialysis Transplantation · 2018 · 111 citations · Full text

Medicine, Nephrology, Pathology +17